Merck KGaA (MKGAF) News Today $134.09 +2.29 (+1.74%) As of 02:27 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestBuy This Stock MKGAF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Merck spends $10 billion for Verona, gaining access to its COPD medicationJuly 9 at 4:49 PM | msn.comMerck KGaA (OTCMKTS:MKGAF) Shares Gap Up - Should You Buy?July 8 at 11:43 AM | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Stock Passes Above Fifty Day Moving Average - What's Next?July 5, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Trading Down 3.9% - What's Next?July 3, 2025 | marketbeat.comMerck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare BusinessJuly 1, 2025 | businesswire.comMerck KGaA (OTCMKTS:MKGAF) Sees Strong Trading Volume - Should You Buy?June 27, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Trading Down 3.2% - What's Next?June 18, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Stock Price Crosses Above Fifty Day Moving Average - Time to Sell?June 11, 2025 | marketbeat.comChina's Center for Drug Evaluation Accepts Merck's Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell TumorJune 9, 2025 | businesswire.comChina's Center for Drug Evaluation Accepts Merck KGaA, Darmstadt, Germany's Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell TumorJune 9, 2025 | businesswire.comMerck KGaA (MKGAF) Files for Global Approval of Pimicotinib After Positive Phase III TGCT ResultsMay 29, 2025 | msn.comMerck KGaA (ETR:MRK) Is Posting Promising Earnings But The Good News Doesn’t Stop ThereMay 22, 2025 | finance.yahoo.comMerck KGaA First Quarter 2025 Earnings: EPS Misses ExpectationsMay 16, 2025 | finance.yahoo.comMerck KGaA (MKGAF) Q1 2025 Earnings Call Highlights: Strong Growth Amidst ChallengesMay 16, 2025 | finance.yahoo.comMerck KGaA Shares Slide After Outlook Cut on Tariff, Currency RisksMay 15, 2025 | msn.comMerck KGaA (MKGAF) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comMerck KGaA strikes more cautious tone on 2025 profitMay 15, 2025 | msn.comMerck KGaA Cuts Outlook Amid Macroeconomic ChallengesMay 15, 2025 | msn.comMerck KGaA Lowers Outlook on Tariff Risks, Currency HeadwindsMay 15, 2025 | bloomberg.comMerck KGaA strikes more cautious tone on 2025 adj profitMay 15, 2025 | reuters.comGermany's Merck drops China surcharge on orders after US-China tariff dealMay 14, 2025 | reuters.comMerck KGaA (OTCMKTS:MKGAF) Short Interest UpdateMay 5, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Shares Cross Below Fifty Day Moving Average - Time to Sell?April 30, 2025 | marketbeat.comGermany's Merck Set to Buy SpringWorks in $3.9 Billion DealApril 28, 2025 | wsj.comGermany's Merck KGaA in $3.9 bln deal to acquire US biotech firm SpringWorksApril 28, 2025 | reuters.comSpringWorks jumps as Merck KGaA reportedly nears $3.5B buyout dealApril 25, 2025 | msn.comMerck KGaA (ETR:MRK) Looks Like A Good Stock, And It's Going Ex-Dividend SoonApril 25, 2025 | finance.yahoo.comAre Investors Undervaluing Merck KGaA (ETR:MRK) By 49%?April 24, 2025 | uk.finance.yahoo.comMerck Q1 Earnings Preview: What to expect?April 23, 2025 | msn.comMerck KGaA (OTCMKTS:MKGAF) Reaches New 1-Year Low - What's Next?April 10, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Reaches New 1-Year Low - Here's What HappenedApril 4, 2025 | marketbeat.comZebra Technologies, Merck KGaA enter safety and traceability solutions pactMarch 29, 2025 | markets.businessinsider.comMerck KGaA (OTCMKTS:MKGAF) Stock Crosses Below 50 Day Moving Average - Should You Sell?March 25, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Sees Significant Growth in Short InterestMarch 18, 2025 | marketbeat.comMerck opens $1 billion addition in north Durham to boost production of popular vaccineMarch 11, 2025 | msn.comMerck KGaA (OTCMKTS:MKGAF) Shares Cross Below 50-Day Moving Average - Time to Sell?March 11, 2025 | marketbeat.comMerck KGaA (MKGAF) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...March 7, 2025 | finance.yahoo.comMerck KGaA sees forex-adjusted earnings growth of up to 8% this yearMarch 6, 2025 | reuters.comMerck KGaA (OTCMKTS:MKGAF) Sees Large Increase in Short InterestMarch 2, 2025 | marketbeat.comSpringWorks Therapeutics jumps after results, conference call cancellationFebruary 20, 2025 | msn.comMorgan Stanley cuts Merck KGaA stock rating, target to EUR160February 12, 2025 | msn.comSpringWorks gets FDA approval for mirdametinibFebruary 11, 2025 | msn.comMerck KGaA (OTCMKTS:MKGAF) Sets New 1-Year Low - Should You Sell?February 10, 2025 | marketbeat.comSpringWorks jumps as Merck KGaA reportedly in talks to acquire companyFebruary 10, 2025 | markets.businessinsider.comMerck KGaA in advanced talks to acquire SpringWorks Therapeutics, Reuters saysFebruary 10, 2025 | markets.businessinsider.comExclusive: Germany's Merck KGaA in talks to buy US cancer biotech firm Springworks, sources sayFebruary 10, 2025 | reuters.comMerck Q4 2024 Earnings Preview: Headwinds ahead, but familiar strengths to persistFebruary 3, 2025 | seekingalpha.comMerck announces $10B share repurchase authorizationJanuary 28, 2025 | markets.businessinsider.comMerck KGaA says high asset prices call for prudent M&A approachJanuary 23, 2025 | reuters.comMerck KGaA (OTCMKTS:MKGAF) Stock Crosses Below 50 Day Moving Average - Time to Sell?January 21, 2025 | marketbeat.com Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MKGAF and its competitors with MarketBeat's FREE daily newsletter. Email Address MKGAF Media Mentions By Week MKGAF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MKGAF News Sentiment▼0.670.56▲Average Medical News Sentiment MKGAF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MKGAF Articles This Week▼41▲MKGAF Articles Average Week Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MKGAF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies UCB News Intra-Cellular Therapies News MorphoSys News Evotec News Calliditas Therapeutics AB (publ) News Zymeworks News Chimerix News Avid Bioservices News MBX Biosciences News Revance Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MKGAF) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MKGAF Stock Alerts